Nuclear protein kinase C isoforms: Key players in multiple cell functions?

Histology and Histopathology

Volumn 18, Issue 4, 2003, Pages 1301-1312

  Martelli, Alberto M ^a,b   Faenza, I ^a   Billi, A M ^a   Fala F ^a   Cocco, L ^a   Manzoli, L ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b CNR   (Italy)

Author keywords

Apoptosis; Differentiation; Phosphorylation; Proliferation; Signal transduction

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CHELERYTHRINE; CHELERYTHRINE CHLORIDE; DIACYLGLYCEROL; ETOPOSIDE; LIPID; NUCLEAR PROTEIN; PHOSPHOTRANSFERASE; PROTEIN KINASE C INHIBITOR; PROTEIN KINASE C ISOENZYME; PROTEIN SERINE THREONINE KINASE; ROTTLERIN; UNCLASSIFIED DRUG; WORTMANNIN;

APOPTOSIS; CATALYSIS; CELL ACTIVATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL MEMBRANE; CELL NUCLEUS; CELL ORGANELLE; CELL PROLIFERATION; CELL SPECIFICITY; CELL STIMULATION; CELL TYPE; CYTOPLASM; DOSE RESPONSE; DRUG INHIBITION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME CONFORMATION; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; ENZYME SUBSTRATE; EVIDENCE BASED MEDICINE; HUMAN; MALIGNANT TRANSFORMATION; METABOLIC REGULATION; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; REVIEW; SECOND MESSENGER; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL DIVISION; CELL NUCLEUS; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; ISOENZYMES; PROTEIN KINASE C; SECOND MESSENGER SYSTEMS;

EID: 0142031096     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (116)

1. Barry O.P. and Kazanietz M.G. (2001). Protein kinase C isozymes, novel phorbol ester receptors and cancer chemotherapy. Curr. Pharm. Des. 7, 1725-1744.
2. Bastiaens P.I.H. and Jovin T.M. (1996). Microspectroscopic imaging tracks the intracellular processing of a signal transduction protein: Fluorescent-labeled protein kinase C β I. Proc. Natl. Acad. Sci. USA 93, 8407-8412.
3. Beckmann R., Lindschau C., Haller H., Hucho F. and Buchner K. (1994). Differential nuclear localization of protein kinase C isoforms in neuroblastoma x glioma hybrid cells. Eur. J. Biochem. 222, 335-343.
4. Berezney R. (2002). Regulating the mammalian genome: The role of nuclear architecture. Advan. Enzyme Regul. 42, 39-52.
5. Berns H., Humar R., Hengerer B., Kiefer F.N. and Battegay E.J. (2000). RACK1 is up-regulated in angiogenesis and human carcinomas. FASEB J. 14, 2549-2558.
6. Bertolaso L., Gibellini D., Secchiero P., Previati M., Falcione D., Visani G., Rizzoli R., Capitani S. and Zauli G. (1998). Accumulation of catalytically active PKC-ζ into the nucleus of HL-60 cell line plays a key role in the induction of granulocytic differentiation mediated by all-trans retinoic acid. Brit. J. Haematol. 100, 541-549.
7. Beyersmann D., Block C. and Malviya A.N. (1994). Effects of cadmium on nuclear protein kinase C. Environ. Health Perspect. 102, 177-180.
8. Blass M., Kronfeld I., Kazimirsky G., Blumberg P.M. and Brodie C. (2002). Tyrosine phosphorylation of protein kinase Cδ is essential for its apoptotic effect in response to etoposide. Mol. Cell. Biol. 22, 182-195.
9. Brodie C. and Blumberg P.M. (2003). Regulation of cell apoptosis by protein kinase C δ. Apoptosis 8, 19-27.
10. Broers J.L.V., Machiels B.M., Van Eys G.J.J.M., Kuijpers H.J.H., Manders E.M.M., Van Driel R. and Ramaekers F.C.S. (1999). Dynamics of the nuclear lamina as monitored by GFP-tagged A-type lamins. J. Cell Sci. 112, 3463-3475.
11. Buchner K. (1995). Protein kinase C in the transduction of signals toward and within the cell nucleus. Eur. J. Biochem. 228, 211-221.
12. Buchner K. (2000). The role of protein kinase C in the regulation of cell growth and in signalling to the cell nucleus. J. Cancer Res. Clin. Oncol. 126, 1-11.
13. Calcerrada M.C., Miguel B.G., Martin L., Catalan R.E. and Martinez A.M. (2002). Involvement of phosphatidylinositol 3-kinase in nuclear translocation of protein kinase C ζ induced by C2-ceramide in rat hepatocytes. FEBS Lett. 514, 361-365.
14. Capitani S., Girard P.R., Mazzei G.J., Kuo J.F., Berezney R. and Mansoli, F.A. (1987). Immunochemical characterization of protein kinase C in rat liver nuclei and subnuclear fractions. Biochem. Biophys. Res. Commun. 142, 367-375.
15. Cataldi A., Miscia S., Centurione L., Rapino M., Bosco D., Grifone G., Di Valerio V., Garaci F. and Rana R. (2002). Role of nuclear PKC δ in mediating caspase-3-upregulation in Jurkat T leukemic cells exposed to ionizing radiation. J. Cell. Biochem. 86, 553-560.
16. Cataldi A., Di Pietro R., Centurione L., Rapino M., Santavenere E., Garaci F., Cocco L., Giuliani-Piccari G. and Rana R. (2003). Engagement of PI-3-kinase mediated protein kinase C ζ activation in protecting Friend cells from ionizing radiation-induced apoptosis. Int. J. Oncol. 22, 129-135.
17. Chapline C., Cottom J., Tobin H., Hulmes J., Crabb J. and Jaken S. (1998). A major, transformation-sensitive PKC-binding protein is also a PKC substrate involved in cytoskeletal remodeling. J. Biol. Chem. 273, 19482-19489.
18. Chapline C., Mousseau B., Ramsay K., Duddy S., Li Y., Kiley S.C. and Jaken S. (1996). Identification of a major protein kinase C-binding protein and substrate in rat embryo fibroblasts. Decreased expression in transformed cells. J. Biol. Chem. 271, 6417-6122.
19. Chiarini A., Whitfield J.F., Armato U. and Dal Pra I. (2002). Protein kinase C-β II is an apoptotic lamin kinase in polyomavirus-transformed, etoposide-treated pyF111 rat fibroblasts. J. Biol. Chem. 277, 18827-18839.
20. Cross T., Griffiths G., Deacon E., Sallis R., Gough M., Wattrs D. and Lord J.M. (2000). PKC-δ is an apoptotic lamin kinase. Oncogene 19, 2331-2337.
21. Deacon E.M., Pettitt T.R., Webb P., Cross T., Chahal H., Wakelam M.J.O. and Lord J.M. (2002). Generation of diacylglycerol molecular species through the cell cycle: A role for 1-stearoyl, 2-arachidonyl glycerol in the activation of nuclear protein kinase C-βII at G2/M. J. Cell Sci. 115, 983-989.
22. Dempsey E.C., Newton A.C., Mochly-Rosen D., Fields A.P., Reyland M.E., Insel P.A. and Messing R.O. (2000). Protein kinase C isozymes and the regulation of diverse cell responses. Am. J. Physiol. 279, L429-438.
23. DeVries T.A., Neville M.C. and Reyland M.E. (2002). Nuclear import of PKCδ is required for apoptosis: Identification of a novel nuclear import sequence. EMBO J. 22, 6050-6060.
24. Divecha N., Banfic H. and Irvine R.F. (1991). The polyphosphoinositide cycle exists in the nuclei of Swiss 3T3 cells under the control of a receptor (for IGF-I) in the plasma membrane, and stimulation of the cycle increases nuclear diacylglycerol and apparently induces translocation of protein kinase C to the nucleus. EMBO J. 10, 3207-3214.
25. Divecha N., Clarke J.H., Roefs M., Halstead J.R. and D'Santos C. (2000). Nuclear inositides: Inconsistent consistencies. Cell. Mol. Life Sci. 57, 379-393.
26. Dorn II G.W., Souroujon M.C., Liron T., Chen C.-H., Gray M.O., Zhou H.Z., Csukai M., Wu G., Lorenz J.N. and Mochly-Rosen D. (1999). Sustained in vivo cardiac protection by a rationally designed peptide that causes ε protein kinase C translocation. Proc. Natl. Acad. Sci. USA 96, 12798-12803.
27. Edwards A.S. and Newton A.C. (1997). Phosphorylation at conserved carboxyl-terminus hydrophobic motif regulates the catalytic and regulatory domains of protein kinase C. J. Biol. Chem. 272, 18382-18390.
28. Eitel K., Staiger H., Rieger J., Mischak H., Brandhorst H., Brendel M.D., Bretzel R.G., Haring H.U. and Kellerer M. (2003). Protein kinase C δ activation and translocation to the nucleus are required for fatty acid-induced apoptosis of insulin-secreting cells. Diabetes 52, 991-997.
29. Fan H.-Y., Tong C., Li M.-Y., Lian L., Chen D.-Y., Schatten H. and Sun Q.-S. (1990). Translocation of the classic protein kinase C isoforms in porcine oocytes: Implications of protein kinase C involvement in the regulation of nuclear activity and cortical granule exocytosis. Exp. Cell Res. 277, 183-191.
30. Fields A.P., Tyler G., Kraft A.S. and May W.S. (1990). Role of nuclear protein kinase C in the mitogenic response to platelet-derived growth factor. J. Cell Sci. 96, 107-114.
31. Ginisty H., Sicard H., Roger B. and Bouvet P. (1999). Structure and functions of nucleolin. J. Cell Sci. 112, 761-772.
32. Gökmen-Polar Y., Murray N.R., Velasco M.A., Gatalica Z. and Fieds A.P. (2001). Elevated protein kinase C βII is an early promotive event in colon carcinogenesis. Cancer Res. 61, 1375-1381.
33. Gross V.L., Hocever B.A., Thompson L.J., Stratton C.A., Burns D.J. and Fields A.P. (1994). Identification of nuclear β II protein kinase C as a mitotic lamin kinase. J. Biol. Chem. 269, 19074-19080.
34. Hocevar B.A. and Fields A.P. (1991). Selective translocation of β II-protein kinase C to the nucleus of human promyelocytic (HL60) leukemia cells. J. Biol. Chem. 266, 28-33.
35. Hocevar B.A., Burns D.J. and Fields A.P. (1993). Identification of protein kinase C (PKC) phosphorylation sites on human lamin B. Potential role of PKC in nuclear lamina structural dynamics. J. Biol. Chem. 268, 7545-7552.
36. Hocevar B.A., Morrow D.M., Tykocinski M.L. and Fields A.P. (1992). Protein kinase C isotypes in human erythroleukemia cell proliferation and differentiation. J. Cell Sci. 101, 671-679.
37. Hofmann J. (2001). Modulation of protein kinase C in antitumor treatment. Rev. Physiol. Biochem. Pharmacol. 142, 1-96.
38. Hug H. and Sarre T.F. (1993). Protein kinase C isoenzymes: Divergence in signal transduction? Biochem. J. 291, 329-343.
39. Hyatt S.L., Liao L., Chapline C. and Jaken S. (1994). Identification and characterization of α-protein kinase C binding proteins in normal and transformed REF52 cells. Biochemistry 33, 1223-1228.
40. Izumi Y., Hirai S., Tamai Y., Fujise-Matsuoka A., Nishimura Y. and Ohno S. (1997). A protein kinase Cδ-binding protein SRBC whose expression is induced by serum starvation. J. Biol. Chem. 272, 7381-7389.
41. Jaken S. and Parker P.J. (2000). Protein kinase C binding partners. Bioessays 22, 245-2354.
42. Jans D.A., Xiao C. and Lam M.H.C. (2000). Nuclear targeting signal recognition: A key control point in nuclear transport? Bioessays 22, 532-544.
43. Johnson J.A., Gray M.O., Chen C.-H. and Mochly-Rosen D. (1996). A protein kinase C translocation inhibitor as an isoenzyme-selective antagonist of cardiac function. J. Biol. Chem. 271, 24962-24966.
44. Keranen L.M. and Newton A.C. (1997). Ca2+ differentially regulates conventional protein kinase Cs' membrane interaction and activation. J. Biol. Chem. 272, 25959-25967.
45. Kikkawa U., Matsuzaki H. and Yamamoto T. (2002). Protein kinase Cδ: Activation mechanisms and functions. J. Biochem. 132, 831-839.
46. La Porta C.A. and Comolli R. (1994). Membrane and nuclear protein kinase C activation in the early stages of diethylnitrosamine-induced rat hepatocarcinogenesis. Carcinogenesis 15, 1743-1747.
47. La Porta C.A., Tessitore L. and Comolli R. (1997). Changes in protein kinase C α, δ and in nuclear β isoform expression in tumour and lung metastatic nodules induced by diethylnitrosamine in the rat. Carcinogenesis 18, 715-719.
48. Leach K.L., Powers E.A., Ruff V.A., Jaken S. and Kaufmann S. (1989). Type 3 protein kinase C localization to the nuclear envelope of phorbol ester-treated NIH 3T3 cells. J. Cell Biol. 109, 685-695.
49. Liao L., Hyatt S.L., Chapline C. and Jaken S. (1994). Protein kinase C domains involved in interactions with other proteins. Biochemistry 33, 1229-1233.
50. Mallia C.M., Aguirre V., McGary E., Scandurro A., Noguki C. and Beckman B.S. (1999). Protein kinase C α is an effector of hexamethylene bisacetamide-induced differentiation of Friend erythroleukemia cells. Exp. Cell Res. 246, 348-354.
51. Mansat-De Ma V., De Thonel A., Gaulin V., Demu C., Laurent G. and Quillet-Mary A. (2002). Protein kinase C-ζ overexpression induces erythroid phenotype in the monocytic leukaemia cell line U937. Brit. J. Haematol. 118, 646-653.
52. Maraldi N.M., Zini N., Santi S. and Manzoli F.A. (1999). Topology of inositol lipid signal transduction in the nucleus. J. Cell. Physiol. 181, 203-217.
53. Martelli A.M., Sang N., Borgatti P., Capitani S. and Neri L.M. (1999). Multiple biological responses activated by nuclear protein kinase C. J. Cell. Biochem. 74, 499-521.
54. Martelli A.M., Tabellini G., Bortul R., Manzoli L., Bareggi R., Baldini G., Grill V., Zweyer M., Narducci P. and Cocco L. (2000). Enhanced nuclear diacylglycerol kinase activity in response to a mitogenic stimulation of quiescent Swiss 3T3 cells with insulin-like growth factor I. Cancer Res. 60, 815-821.
55. Martelli A.M., Zweyer M., Ochs R.L., Tazzari P.L., Tabellini G., Narducci P. and Bortul R. (2001). Nuclear apoptotic changes: An overview. J. Cell. Biochem. 82, 634-646.
56. Martelli A.M., Falcieri E., Zweyer M., Bortul R., Tabellini G., Cappellini A., Cocco L. and Manzoli L. (2002a). The controversial nuclear matrix: A balanced point of view. Histol. Histopathol. 17, 1193-1205.
57. Martelli A.M., Bortul R., Tabellini G., Faenza I., Cappellini A., Bareggi R., Manzoli L. and Cocco L. (2002b). Molecular characterization of protein kinase C-α binding to lamin A. J. Cell Biochem. 86, 320-330.
58. Mizukami Y., Hirata T. and Yoshida K. (1997). Nuclear translocation of PKC ζ during ischemia and its inhibition by wortmannin, an inhibitor of phosphatidylinositol 3-kinase. FEBS Lett. 401, 247-251.
59. Mochly-Rosen D. and Gordon A.S. (1998). Anchoring proteins for protein kinase C: A means for isozyme selectivity. FASEB J. 12, 35-42.
60. Moir R.D., Spann T.P. and Goldman R.D. (1995). The dynamic properties and possible functions of nuclear lamins. Int. Rev. Cytol., 162B, 141-182.
61. Murray N.R. and Fields A.P. (1998). Phosphatidylglycerol is a physiologic activator of nuclear protein kinase C. J. Biol. Chem. 273, 11514-11520.
62. Murray N.R., Davidson L.A., Chapkin R.S., Gustafson W.C., Schattenberg D.G. and Fields A.P. (1999). Overexpression of protein kinase C βII induces colonic hyperproliferation and increased sensitivity to colon carcinogenesis. J. Cell Biol. 145, 699-711.
63. Murray N.R., Burns D.J. and Fields A.P. (1994). Presence of a β II protein kinase C-selective nuclear membrane activation factor in human leukemia cells. J. Biol. Chem. 269, 21385-12390.
64. Musashi M., Ota S. and Shiroshita N. (2000). The role of protein kinase C isoforms in cell proliferation and apoptosis. Int. J. Hematol. 72, 12-19.
65. Neri L.M., Billi A.M., Manzoli L., Rubbini S., Gilmour R.S., Cocco L. and Martelli A.M. (1994). Selective nuclear translocation of protein kinase C α in Swiss 3T3 cells treated with IGF-I, PDGF and EGF. FEBS Lett. 347, 63-68.
66. Neri L.M., Borgatti P., Capitani S. and Martelli A.M. (1998). Nuclear diacylglycerol produced by phosphoinositide-specific phospholipase C is responsible for nuclear translocation of protein kinase C-α. J. Biol. Chem. 273, 29738-29744.
67. Neri L.M., Martelli A.M., Colamussi M.L., Borgatti P., Marchisio M. and Capitani S. (1999). Increase in nuclear phosphatidylinositol 3-kinase activity and phosphatidylinositol (3,4,5) trisphosphate synthesis precede PKC-ζ translocation to the nucleus of NGF-treated PC12 cells. FASEB J. 13, 2299-2310.
68. Neri L.M., Borgatti P., Capitani S. and Martelli A.M. (2002a). Protein kinase C isoforms and lipid second messengers: A critical nuclear partnership? Histol. Histopathol. 17, 1311-1316.
69. Neri L.M., Bortul R., Borgatti P., Tabellini G., Baldini G., Capitani S. and Martelli A.M. (2002b). Proliferating or differentiating stimuli act on different lipid-dependent signaling pathways in nuclei of human leukemia cells. Mol. Biol. Cell 13, 947-964.
70. Newton A.C. (1997). Regulation of protein kinase C. Curr. Opin. Cell Biol. 9, 161-167.
71. Newton A.C. (2001). Protein kinase C: Structural and spatial regulation by phosphorylation, cofactors, and macromolecular interactions. Chem. Rev. 101, 2353-2364.
72. Nickerson J.A. (2001). Experimental observations of a nuclear matrix. J. Cell Sci. 114, 463-474.
73. Nishizuka Y. (1995). Protein kinase C and lipid signaling for sustained cellular responses. FASEB J. 9, 484-496.
74. Ogawa H., Inouye S., Tsuji F.I., Yasuda K. and Umesono K. (1995). Localization, trafficking, and temperature-dependence of the Aequorea green fluorescent protein in cultured vertebrate cells. Proc. Natl. Acad. Sci. USA 92, 11899-11903.
75. Olson E.N., Burgess R. and Staudinger J. (1993). Protein kinase C as a transducer of nuclear signals. Cell Growth Diff. 4, 699-705.
76. Olson K.R., McIntosh J.R. and Olmsted J.B. (1995). Analysis of MAP 4 function in living cells using green fluorescent protein (GFP) chimeras. J. Cell Biol. 130, 639-650.
77. Patel T., Gores G.J. and Kaufmann S.H. (1996). The role of proteases during apoptosis. FASEB J. 10, 587-597.
78. Paulin-Levasseur M. and Julien M. (1992). Expression of intermediate filament proteins in TPA-induced MPC-11 and HL-60 cells. Exp. Cell Res. 199, 363-372.
79. Perander M., Bjorkoy G. and Johansen T. (2001). Nuclear import and export signals enable rapid nucleocytoplasmic shuttling of the atypical protein kinase Cλ. J. Biol. Chem. 276, 13015-13024.
80. Pierce A., Heyworth C.M., Nicholls S.E., Spooncer E., Dexter T.M., Lord J.M., Owen-Lynch P.J., Wark G. and Whetton A.D. (1998). An activated protein kinase C α gives a differentiation signal for hematopoietic progenitor cells and mimicks macrophages colony-stimulating factor-stimulated signaling events. J. Cell Biol. 140, 1511-1518.
81. Reed C.J. (2000). Apoptosis and cancer: Strategies for integrating programmed cell death. Semin. Hematol. 37, 9-16.
82. Rizzuto R., Brini M., Pizzo P., Murgia M. and Pozzan T. (1995). Chimeric green fluorescent protein as a tool for visualizing subcellular organelles in living cells. Curr. Biol. 5, 636-642.
83. Robertson J.D., Orrenius S. and Zhivotovsky B. (2000). Review: Nuclear events in apoptosis. J. Struct. Biol. 129,346-358.
84. Ron D. and Kazanietz M.G. (1999). New insights into the regulation of protein kinase C and novel phorbol ester receptors. FASEB J. 13, 1658-1673.
85. Ron D., Luo J. and Mochly-Rosen D. (1995). C2 region-derived peptides inhibit translocation and function of β protein kinase C in vivo. J. Biol. Chem. 270, 24180-24187.
86. Ron D. and Mochly-Rosen D. (1995). An autoregulatory region in protein kinase C: The pseudoanchoring site. Proc. Natl. Acad. Sci. USA 92, 492-496.
87. Ron D., Vagts A.J., Dohrman D.P., Yaka R., Jiang Z., Ya L., Crabbe J., Grisel J.E. and Diamond I. (2000). Uncoupling of βIIPKC from its targeting protein RACK1 in response to ethanol in cultured cells and mouse brain. FASEB J. 14, 2303-2314.
88. Rosenberger U., Lehmann I., Weise C., Franke P., Hucho F. and Buchner K. (2002). Identification of PSF as a protein kinase Cα-binding protein in the cell nucleus. J. Cell. Biochem. 86, 394-402.
89. Ruchaud S., Korfali N., Villa P., Kottke T.J., Dingwall C., Kaufmann S.H. and Earnshaw W.C. (2002). Caspase-6 gene disruption reveals a requirement for lamin A cleavage in apoptotic chromatin condensation. EMBO J. 21, 1967-1977.
90. Schmalz D., Kalkbrenner F., Hucho F. and Buchner K. (1996). Transport of protein kinase C α into the nucleus requires intact cytoskeleton while the transport of a protein containing a canonical nuclear localization signal does not. J. Cell Sci. 109, 2401-2406.
91. Schmalz D., Hucho F. and Buchner K. (1998). Nuclear import of protein kinase C occurs by a mechanism distinct from the mechanism used by proteins with a classical nuclear localization signal. J. Cell Sci. 111, 1823-1830.
92. Schullery D.S., Ostrowski J., Denisenko O.N., Stempka L., Shnyreva M., Suzuki H., Gschwend M. and Bomsztyk K. (1999). Regulated interaction of protein kinase Cδ with the heterogeneous nuclear ribonucleoprotein K protein. J. Biol. Chem. 274, 15101-15109.
93. Shimizu T., Cao C.X., Shao R.G. and Pommier Y. (1998). Lamin B phosphorylation by protein kinase C α and proteolysis during apoptosis in human leukemia HL60 cells. J. Biol. Chem. 273, 8669-8674.
94. Shirai Y. and Saito N. (2002). Activation mechanisms of protein kinase C: Maturation, catalytic activation, and targeting. J. Biochem. 132, 663-668.
95. Steen R.L., Beullens M., Landsverk H.B., Bollen M. and Collas P. (2003). AKAP149 is a novel PP1 specifier required to maintain nuclear envelope integrity in G1 phase. J. Cell Sci. 116, 2237-2246.
96. Sun B., Murray N.R. and Fields A.P. (1997). A role for nuclear phosphatidylinositol-specific phospholipase C in the G2/M phase transition. J. Biol. Chem. 272, 26313-26317.
97. Tabellini G., Bortul R., Aluigi M., Billi A.M., Bareggi R., Grill V., Narducci P. and Martelli A.M. (2002). Binding of elements of protein kinase C-α regulatory domain to lamin B1. Cell. Signal 14, 819-827.
98. Thompson L.J. and Fields A.P. (1996). βII protein kinase C is required for the G2/M phase transition of cell cycle. J. Biol. Chem. 271, 15045-15053.
99. Thornberry N.A. and Lazebnik Y. (1998). Caspases: Enemies within. Science 281, 1312-1316.
100. Trubiani O., Borgatti P. and Di Primio R. (1994). Protein kinase C modulation in apoptotic rat thymocytes: An ultrastructural analysis. Histochemistry 102, 311-316.
101. Unger R.H. and Orci L. (2002). Lipoapoptosis: Its mechanisms and its diseases. Biochim. Biophys. Acta 1585, 202-212.
102. Utz P.J. and Anderson P. (2000). Life and death decisions: Regulation of apoptosis by proteolysis of signaling molecules. Cell Death Diff. 7, 589-602.
103. Vandromme M., Cavadore J.-C., Bonnieu A., Froeschlé A., Lamb N. and Fernandez A. (1995). Two nuclear localization signals present in the basic-helix 1 domains of MyoD promote its active nuclear translocation and can function independently. Proc. Natl. Acad. Sci. USA 92, 4646-4650.
104. Vaux D.L. and Korsmeyer S.J. (1999). Cell death in development. Cell 96, 245-254.
105. Ventura C. and Maioli M. (2001). Protein kinase C control of gene expression. Crit. Rev. Eukaryot. Gene Expr. 11, 243-267.
106. Ventura C., Pintus G., Fiori M.G., Bennardini F., Pinna G. and Gaspa L. (1997). Opioid peptide gene expression in the primary hereditary cardiomyopathy of the Syrian hamster. J. Biol. Chem. 272, 6685-6692.
107. Ventura C., Maioli M., Pintus G., Posadino A.M. and Tadolini B. (1998). Nuclear opioid receptors activate opioid peptide gene transcription in isolated myocardial nuclei. J. Biol. Chem. 273, 13383-13386.
108. Ventura C., Maioli M., Pintus G., Gottardi G. and Bersani F. (2000). Elf-pulsed magnetic fields modulate opioid peptide gene expression in myocardial cells. Cardiovasc. Res. 45, 1054-1064.
109. Ventura C., Zinellu E., Maninchedda E. and Maioli M. (2003). Dynorphin B is an agonist of nuclear opioid receptors coupling nuclear protein kinase C activation to the transcription of cardiogenic genes in GTR1 embryonic stem cells. Circ. Res., in press.
110. Wagner S., Harteneck C., Hucho F. and Buchner K. (2000). Analysis of the subcellular distribution of protein kinase C α using PKC-GFP fusion proteins. Exp. Cell Res. 258, 204-214.
111. White W.O., Seibenhener M.L. and Wooten M.W. (2002). Phosphorylation of tyrosine 256 facilitates nuclear import of atypical protein kinase C. J. Cell. Biochem. 85, 42-53.
112. Wooten M.W., Zhou G., Wooten M.C. and Seibenhener M.L. (1997). Transport of protein kinase C isoforms to the nucleus of PC12 cells by nerve growth factor: Association of atypical ζ-PKC with the nuclear matrix. J. Neurosci. Res. 49, 393-403.
113. Xu A., Wang Y., Xu L.Y. and Gilmour R.S. (2001). Protein kinase C α - Mediated negative feedback regulation is responsible for the termination of insulin-like growth factor I-induced activation of nuclear phospholipase C β1 in Swiss 3T3 cells. J. Biol. Chem. 276, 14980-14986.
114. Yedovitzky M., Mochly-Rosen D., Johnson J.A., Gray M.O., Ron D., Abramovitch E., Cerasi E. and Nesher R. (1997). Translocation inhibitors define specificity of protein kinase C isoenzymes in pancreatic β cells. J. Biol. Chem. 272, 1417-1420.
115. Zhou G., Seibenhener M.L. and Wooten M.W. (1997). Nucleolin is a protein kinase C-ζ substrate. Connection between cell surface signaling and nucleus in PC12 cells. J. Biol. Chem. 272, 31130-31137.
116. Zini N., Martelli A.M., Neri L.M., Bavelloni A., Sabatelli P., Santi S. and Maraldi N.M. (1995). Immunocytochemical evaluation of protein kinase C translocation to the inner nuclear matrix in 3T3 mouse fibroblasts after IGF-I treatment. Histochemistry 103, 447-457.